• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Human-nonhuman chimeras: a regulatory proposal on the blurring of species lines.

作者信息

Kopinksi Nicole E

出版信息

Boston Coll Law Rev. 2004 May;45(3):619-66.

PMID:16514749
Abstract

The chimera of modern biotechnology is defined broadly as a single organism composed of a mixture of materials from two or more organisms possessing distinct genetic backgrounds. Unlike the United States, which does not regulate chimeras directly, Canada has responded to the unregulated pursuit of chimera technology by banning certain chimeras as part of comprehensive legislation designed to regulate human reproductive technologies. In 2004, the Canadian Parliament passed the Assisted Human Reproduction Act despite criticism urging greater legislative justification for the Act's provisions and modification to it statutory definitions. Because current regulatory mechanisms in the United States, including patent law and administrative oversight, fail to regulate chimera technology, the United States should enact new legislation, using Canada's legislation as a model, to prohibit embryonic chimeras and to regulate other human-nonhuman combinations. Unregulated biotechnology threatens to disrupt legal and social institutions; therefore, the United States must make a balanced effort now to protect the public interest.

摘要

相似文献

1
Human-nonhuman chimeras: a regulatory proposal on the blurring of species lines.
Boston Coll Law Rev. 2004 May;45(3):619-66.
2
Canada's Assisted Human Reproductive Act: is it scientific censorship, or a reasoned approach to the regulation of rapidly emerging reproductive technologies?加拿大的《人类辅助生殖法案》:这是科学审查,还是对迅速涌现的生殖技术进行监管的合理方式?
Sask Law Rev. 2004;67(1):97-135.
3
The human use of humanoid beings: chimeras and patent law.人类对类人生命体的利用:嵌合体与专利法。
Nat Biotechnol. 2006 May;24(5):517-9. doi: 10.1038/nbt0506-517.
4
Creating clones, kids & chimera: liberal democratic compromise at the crossroads.创造克隆体、儿童与嵌合体:处于十字路口的自由民主妥协
Notre Dame J Law Ethics Public Policy. 2003;17(1):71-149.
5
Politics, prohibitions and the lost public perspective: a comment on Bill C-56: the Assisted Human Reproduction Act.政治、禁令与公众视角的缺失:对C-56法案《辅助人类生殖法案》的评论
Alta Law Rev. 2002 Sep;40(2):451-63.
6
Regulation of assisted reproductive technologies in the United States.
Fam Law Q. 2005 Fall;39(3):727-44.
7
What is an embryo?什么是胚胎?
Conn Law Rev. 2004 Summer;36(4):1051-92.
8
A postmodernist take on the human embryo research debate.
Conn Law Rev. 2004 Summer;36(4):1133-61.
9
Reproductive and therapeutic cloning, germline therapy, and purchase of gametes and embryos: comments on Canadian legislation governing reproduction technologies.生殖性克隆与治疗性克隆、生殖系治疗以及配子和胚胎的购买:关于加拿大生殖技术相关立法的评论
J Med Ethics. 2004 Dec;30(6):527-32. doi: 10.1136/jme.2002.002170.
10
The year of the stem cell: George Annas talks about the future of stem cell research in America.干细胞之年:乔治·安纳斯谈美国干细胞研究的未来。
Genewatch. 2005 Sep-Oct;18(5):12-5.

引用本文的文献

1
Clarifying the Ethics and Oversight of Chimeric Research.阐明嵌合体研究的伦理和监督问题。
Hastings Cent Rep. 2022 Nov;52 Suppl 2(Suppl 2):S2-S23. doi: 10.1002/hast.1427.
2
Regulatory and intellectual property conundrums surrounding xenotransplantation.围绕异种移植的监管和知识产权难题。
Nat Biotechnol. 2021 Jul;39(7):796-798. doi: 10.1038/s41587-021-00976-7.
3
The gap between law and ethics in human embryonic stem cell research: overcoming the effect of U.S. federal policy on research advances and public benefit.
人类胚胎干细胞研究中法律与伦理的差距:克服美国联邦政策对研究进展和公共利益的影响。
Sci Eng Ethics. 2005 Oct;11(4):589-616. doi: 10.1007/s11948-005-0028-x.